![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2008 The Author(s) Divergence of selenocysteine tRNA recognition by archaeal and eukaryotic O-phosphoseryl-tRNASec kinase 1Department of Molecular Biophysics and Biochemistry and 2Department of Chemistry, Yale University, New Haven, CT 06520-8114, USA *To whom correspondence should be addressed. Phone: +1 203 432 6200, Fax: +1 203 432 6202, Email: dieter.soll/at/yale.edu Received December 18, 2007; Revised January 18, 2008; Accepted January 21, 2008. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. This article has been cited by other articles in PMC.Abstract Selenocysteine (Sec) biosynthesis in archaea and eukaryotes requires three steps: serylation of tRNASec by seryl-tRNA synthetase (SerRS), phosphorylation of Ser-tRNASec by O-phosphoseryl-tRNASec kinase (PSTK), and conversion of O-phosphoseryl-tRNASec (Sep-tRNASec) by Sep-tRNA:Sec-tRNA synthase (SepSecS) to Sec-tRNASec. Although SerRS recognizes both tRNASec and tRNASer species, PSTK must discriminate Ser-tRNASec from Ser-tRNASer. Based on a comparison of the sequences and secondary structures of archaeal tRNASec and tRNASer, we introduced mutations into Methanococcus maripaludis tRNASec to investigate how Methanocaldococcus jannaschii PSTK distinguishes tRNASec from tRNASer. Unlike eukaryotic PSTK, the archaeal enzyme was found to recognize the acceptor stem rather than the length and secondary structure of the D-stem. While the D-arm and T-loop provide minor identity elements, the acceptor stem base pairs G2-C71 and C3-G70 in tRNASec were crucial for discrimination from tRNASer. Furthermore, the A5-U68 base pair in tRNASer has some antideterminant properties for PSTK. Transplantation of these identity elements into the tRNASerUGA scaffold resulted in phosphorylation of the chimeric Ser-tRNA. The chimera was able to stimulate the ATPase activity of PSTK albeit at a lower level than tRNASec, whereas tRNASer did not. Additionally, the seryl moiety of Ser-tRNASec is not required for enzyme recognition, as PSTK efficiently phosphorylated Thr-tRNASec. INTRODUCTION While UGA is typically a stop codon, selenocysteine is co-translationally inserted into proteins in response to in-frame Sec-decoding UGA codons in a limited number of organisms from all three domains of life (1). Sec is formed by a tRNA-dependent transformation of Ser to Sec. In Sec-decoding organisms, tRNASec is first aminoacylated with Ser by SerRS (2–4). Bacteria convert Ser to Sec in one step using selenocysteine synthase (SelA) in the presence of the selenium donor selenophosphate (1). Eukaryotes and archaea perform the Ser to Sec conversion using two enzymes: PSTK phosphorylates the serine moiety of Ser-tRNASec to Sep-tRNASec (5–8), and SepSecS catalyzes the Sep-tRNASec to Sec-tRNASec conversion (9,10). About four decades ago the presence of a Sep-tRNA was discovered in rooster (11) and rat liver (12) and later in other eukaryotes and archaea (5,13–15). Also established early (14) was the Sep-tRNA synthesis requirement for two enzymes, SerRS and a ‘phosphotransferase activity’. The latter enzyme was purified from bovine liver (7), the human counterpart was characterized with regard to tRNA recognition (8) and finally the protein responsible was identified (5) as PSTK. Detailed characterizations of PSTK activity were subsequently performed on the mouse (5) and Methanocaldococcus jannaschii enzyme (15). PSTK transfers the γ-phosphate from ATP to Ser-tRNASec yielding Sep-tRNASec and ADP (5,15). tRNASec binds to PSTK with high affinity and specifically induces its ATPase activity (15). Although SerRS must be able to recognize and aminoacylate both tRNASer and tRNASec, proper interpretation of the genetic code requires that PSTK differentiate Ser-tRNASec from Ser-tRNASer. tRNASec species from all three domains of life are unusual in both length (>90 nt) and structure. While most tRNAs including tRNASer are in a 7/5 cloverleaf form (i.e. 7 bp in the acceptor stem and 5 in the TΨC arm), bacterial tRNASec is in an 8/5 form (16), while eukaryal tRNASec (17,18) and archaeal tRNASec (17,19) likely exist in a 9/4 clover leaf form. Besides the difference in acceptor stem length at 9 bp in archaeal and eukaryotic tRNASec versus 7 bp in tRNASer, several other features of tRNASec are significantly different from tRNASer. Eukaryotic and archaeal tRNASec species have 6 or 7 bp D-stems, respectively (17–19); in contrast tRNASer has a 3 to 4 bp D-stem. Molecular modeling suggested that a 7 bp D-stem in archaeal tRNASec would compensate for the short 4 bp T-stem (5 bp in tRNASer) thus allowing the normal interaction between the D- and T-loops (19). The sequence, length and orientation of the variable arm of tRNASec also vary from those of tRNASer. Previous work with HeLa cell extracts (8) demonstrated that the length and secondary structure of the D-stem of human tRNASec are the major determinants for serine phosphorylation by a kinase activity (in the following called ‘human PSTK’). Here we present the basis of tRNASec discrimination from tRNASer by an archaeal PSTK from M. jannaschii. The G2-C71 and C3-G70 base pairs within the acceptor stem of Methanococcus maripaludis tRNASec are the major identity elements for tRNA-dependent serine phosphorylation by archaeal PSTK. MATERIALS AND METHODS Materials and reagents All oligonucleotide synthesis and DNA sequencing were carried out by the Keck Foundation Biotechnology Research Laboratory at Yale University. L-[U-14C]Ser (163 mCi/mmol) was from Amersham Biosciences and [α-32P]-ATP (3000 Ci/mmol) was from GE Healthcare. L-[1-14C]Thr (50–60 mCi/mmol) was from American Radiolabeled Chemicals. Expression and purification of enzymes Cloning, purification, transcription and 32P-labeling of tRNAs All tRNAs were cloned into pUC19, expressed in E. coli DH5α, transcribed by T7 RNA polymerase, gel purified and folded as described previously (15). Refolded transcript was 32P-labeled on the 3' terminus using the E. coli CCA-adding enzyme and [α-32P]ATP as before (15). After phenol/chloroform extraction the reaction was passed over a Sephadex G25 Microspin column (Amersham Biosciences) to remove excess ATP. Serylation and phosphorylation of tRNASec These assays were carried out in 1× PSTK buffer [50 mM HEPES-KOH (pH 7.5), 10 mM MgCl2, 20 mM KCl, 1 mM DTT] with 1 mM L-Ser (Sigma), 5 mM ATP, 600 nM M. maripaludis SerRS, 50 nM M. jannaschii PSTK and 1 µM 32P-labeled transcript for 45 min at 37°C. Aliquots (2 µl) of each reaction were quenched on ice with 3 µl of 100 mM sodium citrate (pH 5.0) and 0.66 mg/ml nuclease P1 (Sigma) and incubated at room temperature for 35 min (20,21). Assays that included 100 µM [14C]-Ser were carried out in 1× PSTK buffer with 1 µM tRNASec transcript, 5 mM ATP, 1.2 µM SerRS and 200 nM PSTK for 45 min at 37°C. The reactions were stopped by phenol/chloroform extraction and purified over a G25 column to remove unincorporated [14C]-Ser, and aliquots (2 µl) of each reaction were quenched and digested as above. To separate Sep-AMP, Ser-AMP and AMP, 1 µl of quenched, digested sample was spotted on glass polyethyleneimine (PEI) cellulose 20 cm × 20 cm thin layer chromatography (TLC) plates (EMD) and developed for 75 min in 100 mM ammonium acetate and 5% acetic acid. The plates were exposed on an imaging plate (FujiFilms), scanned on a Molecular Dynamics Storm 860 PhosphorImager, and quantified using ImageQuant software. Preparation of seryl-tRNA tRNASec, chimera and tRNASer 32P-labeled transcripts were each aminoacylated in 1× PSTK buffer with 1 mM L-Ser (Sigma), 5 mM ATP, 3 µM M. maripaludis SerRS and 5 µM 32P-labeled transcript as described previously (15). Reactions were incubated at 37°C for 1 h followed by phenol/chloroform extraction, ethanol precipitation and resuspension in water. The samples were passed over Sephadex G25 Microspin columns (Amersham Biosciences) equilibrated with water. To check aminoacylation levels, 2 µl aliquots were removed at the end of the reactions, quenched on ice with 3 µl of 100 mM sodium citrate (pH 5.0) and 0.66 mg/ml nuclease P1 (Sigma), and analyzed as described above. Phosphorylation of seryl-tRNA These assays were carried out in 1× PSTK buffer with 1 µM 32P-labeled Ser-tRNA transcript, 5 mM ATP and 50 nM PSTK at 37°C. Reaction mixes were preincubated at 37°C and started by addition of enzyme. At each time point, 2 µl aliquots were taken and treated as described above. ATPase activity measurement ATPase activity was determined by measuring the amount of [α-32P]ATP converted to [α-32P]ADP as described before with modifications (15). These assays were carried out in a 12 µl reaction volume including 1× PSTK buffer with 130 nM cold ATP, 100 nM [α-32P]ATP and 1 µM enzyme at 37°C for 30 min. Unless noted otherwise, 1 µM unlabeled tRNA (tRNASec, G2-C71:C-G tRNASec, chimera tRNA or tRNASer) was included. At six time points, 0.75 µl aliquots were taken from each reaction and quenched by the addition of 9.25 µl ice-cold 55 mM EDTA. One microliter of each reaction mixture was spotted on PEI cellulose TLC plates (EMD) and developed in 1 M LiCl for 60 to 75 min. After separation, the [α-32P]ATP and [α-32P]ADP spots were quantified by PhosphorImager using ImageQuant software. Secondary structure alignment of archaeal tRNAs Phosphorylation of threonyl-tRNASec These assays were carried out in 1× PSTK buffer with 5 mM ATP, 2.5 mM threonine (Thr) (Fluka, 99.5% purity), 1 µM 32P-labeled tRNASec transcript, 1.2 µM SerRS and with or without 200 nM PSTK for 45 min at 37°C. The reactions were quenched, digested and analyzed by TLC as stated above. RESULTS A survey of tRNA identity elements of archaeal PSTK We decided to undertake a preliminary survey for potential tRNA identity elements for phosphorylation by M. jannaschii PSTK. Our assay conditions (see Materials and Methods section and Table 1) guarantee achievement of plateau levels of Ser-tRNASec formation, while phosphorylation may or may not reach plateau values for all the different mutants. Such an approach will reveal major elements, but will miss some less important ones. Previous work established that Ser-tRNASec but not Ser-tRNASer is a substrate for phosphorylation by PSTK (7,8,12–15). Thus, the identity elements for phosphorylation must lie within tRNASec (Figure 1
The unusual D-arm provides a minor identity element for archaeal PSTK The length and structure but not sequence of the D-stem of human tRNASec were shown to be the major identity elements for serine phosphorylation by human PSTK (8), but our investigation revealed the D-arm to be a minor identity element for archaeal PSTK. The D-arm of tRNASec likely has a 7-bp stem and a 4 nt loop, whereas in the isoacceptors of tRNASer the stem and loop are 3 to 4 bp and 9 to 13 nt, respectively. (Figure 1 PSTK recognition of the acceptor stem of archaeal tRNASec is essential for phosphorylation The acceptor stems of archaeal tRNASec and tRNASer from Sec-decoding archaea differ in both length and sequence (Figure 1 To determine whether the length of the acceptor stem was an important identity element for PSTK recognition of tRNASec, tRNASec mutants with deletions of base pairs within the acceptor stem were analyzed: Δ5a-67b, Δ5b-67a, Δ5a-67b/Δ5b-67a and ΔG2-C71. Deletion of 5a-67b or 5b-67a did not influence phosphorylation efficiency (Table 1). Deletion of both 5a-67b and 5b-67a resulted in mutant tRNASec that serylated poorly, similarly to the acceptor stem + T arm mutant (8.9% and 20.1%, respectively). Unlike the acceptor stem + T arm mutant, the relative phosphorylation efficiency was higher at 54.9% of the wild-type tRNASec level (Table 1). This may suggest that the length of the acceptor stem plays a role in phosphorylation. Additionally, mutant tRNASec with a G2-C71 deletion serylated efficiently (73.4%) but its relative phosphorylation efficiency was only 1.3% (Table 1), signifying a possible sequence-specific interaction with PSTK. Archaeal tRNASec has invariant G2-C71 and C3-G70 base pairs and a well-conserved C5-G68 base pair in the acceptor stem (Figure 1 The anticodon stem–loop and long variable arm are not identity elements for phosphorylation by PSTK The anticodon stem–loop is highly conserved in archaeal tRNASec compared to the anticodon stem–loops of tRNASer isoacceptors (with the anticodons UGA, GGA and GCU) found in Sec-decoding archaea (Figure 1 The T-loop of tRNASec is a minor identity element for phosphorylation The structure of the T-arm of archaeal tRNASec is quite unusual in that the T-stem has 4 bp while most tRNAs, including tRNASer, have 5-bp T-stems (Figure 1 The T-loop size is conserved between archaeal tRNASec and tRNASer but the sequences are variant in two positions, 57 and 59 (Figure 1 Transplantation of acceptor stem base pairs G2-C71, C3-G70 and C5-G68 into tRNASer allows robust phosphorylation by PSTK Although mutation of G2-C71 in tRNASec resulted in a mutant that only phosphorylated at 3.7% of the wild-type level, transplantation of G2-C71 alone into the tRNASerUGA backbone was not sufficient to confer phosphorylation onto this mutant (transplant 1, Table 1). The archaeal tRNASec identity elements found at base pairs G2-C71 and C3-G70 were transplanted into the tRNASerUGA backbone, and the negative determinant A5-U68 was mutated to G5-C68 as found in tRNASec (Figure 1
Chimeric tRNA induces the ATPase activity of PSTK The ATPase activity of PSTK is specifically induced by tRNASec and there was minimal ATPase activity of the enzyme in the presence of tRNASer or in the absence of tRNA (15). When the ATPase activity of PSTK was tested in the presence of the G2-C71 to C-G tRNASec mutant, which was poorly phosphorylated (Table 1), the little ATPase activity detectable was similar to the ATPase activity in the presence of tRNASer (Figure 3
Divergence in tRNASec acceptor stems from Archaea, Eukarya and Bacteria Alignment of archaeal and eukaryal tRNASec by secondary structure (Figure 4
The acceptor stem of bacterial tRNASec consists of 8 bp (16) rather than 9 bp as found in archaeal and eukaryal tRNASec. Acceptor stems from 50 divergent Sec-decoding bacterial species were analyzed, and the G2-C71 bp is highly conserved if not invariant (Figure 4 Amino acid recognition by PSTK It was observed earlier that M. barkeri SerRS misactivates threonine (30) and inefficiently forms Thr-tRNASer (I. Weygand-Durasevic, personal communication). Given that M. jannaschii PSTK has a similar affinity for tRNASec as Ser-tRNASec and thus does not seem to recognize the serine moiety on the tRNA (15), we considered whether PSTK could phosphorylate Thr-tRNASec. M. maripaludis [32P]tRNASec was mischarged with Thr by M. maripaludis SerRS, producing Thr-tRNASec (Figure 5
DISCUSSION The pathway for selenocysteine formation differs in bacteria from that present in eukaryotes and archaea; however, tRNASec remains a common factor for selenocysteine formation among the three. The tRNA-dependent conversion of Ser to Sec in eukaryotes and archaea requires that the unusual tRNASec be recognized initially by enzymes that interact with many tRNAs such as processing and modifying enzymes and the CCA-adding enzyme prior to ‘mischarging’ with Ser by SerRS, phosphorylation of the resulting Ser-tRNASec by PSTK and conversion of Sep-tRNASec to Sec-tRNASec by SepSecS. Subsequently, the tRNASec-specific elongation factor SelB must recognize Sec-tRNASec specifically for selenoprotein synthesis (31–33). While we have speculated that a complex of the enzymes involved in selenocysteine biosynthesis might exist (15) as has been suggested and shown for the tRNA-dependent amidotransferases (34,35), it is not known which components of the pathway might exist in a complex or whether the enzymes might compete for the tRNASec substrate. Yet, PSTK provides the first line of defense in maintaining the fidelity of genetic code translation by binding with high affinity to Ser-tRNASec (7,15). This sequesters mischarged tRNA from use in translation and discriminates Ser-tRNASec from Ser-tRNASer. A previous study detailed how a human PSTK discriminates human Ser-tRNASec from Ser-tRNASer by virtue of the atypical D-stem structure of tRNASec (8). While archaeal tRNASec retains a D-stem structure similar to that of eukaryal tRNASec, mutations that open the last two base pairs in the D-stem of M. maripaludis tRNASec—leading to the formation of a 5-bp rather than a 7-bp stem—did not result in a complete loss of serine phosphorylation by M. jannaschii PSTK as occurred when similar mutations were made to human tRNASec (phosphorylation by human PSTK) (8). Some mutations to the D-stem of M. maripaludis tRNASec (U16A, U16G, U16A/C15G and A20aU) caused a moderate decrease in phosphorylation but others (C15G and A20aC) did not, which brings into question whether a 7-bp stem has an effect on phosphorylation by archaeal PSTK. The intact 7-bp D-stem per se may not be recognized for phosphorylation; these data might suggest a sequence-specific interaction of archaeal PSTK with U16, but the compensatory mutation A20aU/U16A that keeps the D-stem intact phosphorylated efficiently even with a mutation of U16. Perhaps mutations of A20aU or of U16 perturb the tertiary structure of tRNASec, causing the decrease in phosphorylation efficiency by PSTK. The T-loop of tRNASec also provides a minor identity element for archaeal PSTK phosphorylation. The combined mutation of G57A and U59A in the T-loop, which resulted in a T-loop identical to that found in tRNASer from Sec-decoding archaea, caused a moderate decrease in phosphorylation that was not completely attributable to a single mutation of either G57 or U59. Conceivably these mutations, specifically that of U59, could disrupt a tertiary interaction of the D- and T-loops between U17 and U59. A novel tertiary interaction was reported for E. coli tRNASec between C16 (located at the same position as U17 in archaeal tRNASec) in the D-loop and C59 (U59 in archaeal tRNASec) in the T-loop (16) although a similar interaction was not found between U16 (located at the same position as U17 in archaeal tRNASec) and U59 in a study of eukaryotic-type Xenopus laevis tRNASec (18). If archaeal tRNASec is able to form interactions common to all known tRNA crystal structures between the D-loop and T-loop (25–27) as was supported by molecular modeling of the archaeal-type M. jannaschii tRNASec (19), an alternative explanation is possible; nucleotide 57 stacks with other purines in an intercalation of bases from both the D- and T-loops, and nucleotide 59 stacks to the tertiary base pairs 15–48, playing a crucial role in fixing the juxtaposition of domains I (anticodon stem and D-stem) and II (T-stem and acceptor stem) (19). Although nucleotide 57 is typically conserved as a purine and nucleotide 59 can be any nucleotide, the invariant nature of U57 and highly conserved G59 may be essential for tertiary interactions in archaeal tRNASec. A future structural study of archaeal tRNASec would be helpful in making these determinations. Despite the fact that at present we cannot conclusively state that the length of the acceptor stem is involved in phosphorylation of Ser-tRNASec by archaeal PSTK, our data definitively revealed that critical identity elements are found within the acceptor stem. This finding is quite unlike what was shown for eukaryotic-type PSTK and tRNASec where neither the sequence nor length of the acceptor stem was important for phosphorylation (8). Mutagenesis of M. maripaludis tRNASec at the G2-C71 and C3-G70 bp demonstrated their importance for phosphorylation, and transplantation of these base pairs into tRNASerUGA along with mutating the A5-U68 antideterminant endowed efficient phosphorylation to the chimeric tRNA. Additionally, we previously demonstrated that tRNASec stimulated the ATPase activity of PSTK by a potential induced fit mechanism (15); the fact that our chimeric tRNA unlike tRNASer stimulated the ATPase activity of PSTK is further confirmation of the essentiality of the G2-C71 and C3-G70 bp. A fascinating aspect revealed by this study is the divergence in recognition of archaeal and eukaryal tRNASec by archaeal and eukaryal PSTKs; there is precedence for this as aminoacyl-tRNA synthetases from the three domains of life sometimes utilize variant tRNA identity elements (36), and additionally, the tRNA-dependent amidotransferase GatCAB from bacteria and archaea evolved to recognize different elements within tRNAAsn (37,38). While the length and structure of the D-stem of human tRNASec were essential for phosphorylation by human PSTK (8), the unusual D-stem of archaeal tRNASec only moderately affected phosphorylation by archaeal PSTK, possibly by means of maintenance of proper tertiary structure. On the contrary, invariant base pairs within the acceptor stem of archaeal tRNASec were vital for phosphorylation by archaeal PSTK. Moreover, the invariant G2-C71 of archaeal tRNASec was found to be highly conserved as C2-G71 in eukaryotic tRNASec, which resulted in minimal phosphorylation by archaeal PSTK in the context of archaeal tRNASec. This distinction between archaeal and eukaryotic tRNASec corresponds to a deep evolutionary divide between archaeal-type and eukaryotic-type PSTKs (15). While tRNASec transverses interactions with a number of enzymes in the selenocysteine biosynthesis pathway, that distinction may indicate co-evolution of archaeal and eukaryotic tRNASec with their respective PSTKs. SUPPLEMENTARY DATA Supplementary Data are available at NAR Online. ACKNOWLEDGEMENTS We thank Sotiria Palioura, Lennart Randau, Kelly Sheppard and Jing Yuan for helpful discussions and critical reading of the paper. We appreciate the assistance of William B. Whitman in providing us with archaeal tRNASec sequences and Ivana Weygand-Durasevic for helpful advice. R.L.S. is the recipient of a Ruth L. Kirschstein National Research Service Award (F32 GM075602) from the National Institute of General Medical Sciences. J.H. holds an Edward A. Bouchet Undergraduate Fellowship from Yale University. This work was supported by grants from the Department of Energy and the National Institute of General Medical Sciences (to D.S.). Funding to pay the Open Access publication charges for this article was provided by National Institute of General Medical Sciences grant GM22854 (to D.S.). Conflict of interest statement. None declared. REFERENCES 1. Böck A, Thanbichler M, Rother M, Resch A. In: Aminoacyl-tRNA Synthetases. Ibba M, Francklyn C, Cusack S, editors. Georgetown, TX: Landes Bioscience; 2005. pp. 320–327. 2. Bilokapic S, Korencic D, Söll D, Weygand-Durasevic I. The unusual methanogenic seryl-tRNA synthetase recognizes tRNASer species from all three kingdoms of life. Eur. J. Biochem. 2004;271:694–702. [PubMed] 3. Leinfelder W, Zehelein E, Mandrand-Berthelot MA, Böck A. Gene for a novel tRNA species that accepts L-serine and cotranslationally inserts selenocysteine. Nature. 1988;331:723–725. [PubMed] 4. Wu XQ, Gross HJ. The long extra arms of human tRNA((Ser)Sec) and tRNA(Ser) function as major identify elements for serylation in an orientation-dependent, but not sequence-specific manner. Nucleic Acids Res. 1993;21:5589–5594. [PubMed] 5. Carlson BA, Xu XM, Kryukov GV, Rao M, Berry MJ, Gladyshev VN, Hatfield DL. Identification and characterization of phosphoseryl-tRNA[Ser]Sec kinase. Proc. Natl Acad. Sci. USA. 2004;101:12848–12853. [PubMed] 6. Kaiser JT, Gromadski K, Rother M, Engelhardt H, Rodnina MV, Wahl MC. Structural and functional investigation of a putative archaeal selenocysteine synthase. Biochemistry. 2005;44:13315–13327. [PubMed] 7. Mizutani T, Hashimoto A. Purification and properties of suppressor seryl-tRNA: ATP phosphotransferase from bovine liver. FEBS Lett. 1984;169:319–322. [PubMed] 8. Wu XQ, Gross HJ. The length and the secondary structure of the D-stem of human selenocysteine tRNA are the major identity determinants for serine phosphorylation. EMBO J. 1994;13:241–248. [PubMed] 9. Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ, Gladyshev VN, Hatfield DL. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007;5:e4. [PubMed] 10. Yuan J, Palioura S, Salazar JC, Su D, O’Donoghue P, Hohn MJ, Cardoso AM, Whitman WB, Söll D. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc. Natl Acad. Sci. USA. 2006;103:18923–18927. [PubMed] 11. Carlsen EN, Trelle GJ, Schjeide OA. Transfer ribonucleic acids. Nature. 1964;202:984–986. [PubMed] 12. Mäenpää PH, Bernfield MR. A specific hepatic transfer RNA for phosphoserine. Proc. Natl Acad. Sci. USA. 1970;67:688–695. [PubMed] 13. Hatfield D, Diamond A, Dudock B. Opal suppressor serine tRNAs from bovine liver form phosphoseryl-tRNA. Proc. Natl Acad. Sci. USA. 1982;79:6215–6219. [PubMed] 14. Sharp SJ, Stewart TS. The characterization of phosphoseryl tRNA from lactating bovine mammary gland. Nucleic Acids Res. 1977;4:2123–2136. [PubMed] 15. Sherrer RL, O’Donoghue P, Söll D. Characterization and evolutionary history of an archaeal kinase involved in selenocysteinyl-tRNASec formation. Nucleic Acids Res. 2008 doi:10.1093/nar/gkm1134 (Advance access published 3 January 2008). 16. Baron C, Westhof E, Böck A, Giege R. Solution structure of selenocysteine-inserting tRNASec from Escherichia coli. Comparison with canonical tRNASer. J. Mol. Biol. 1993;231:274–292. [PubMed] 17. Hubert N, Sturchler C, Westhof E, Carbon P, Krol A. The 9/4 secondary structure of eukaryotic selenocysteine tRNA: more pieces of evidence. RNA. 1998;4:1029–1033. [PubMed] 18. Sturchler C, Westhof E, Carbon P, Krol A. Unique secondary and tertiary structural features of the eucaryotic selenocysteine tRNASec. Nucleic Acids Res. 1993;21:1073–1079. [PubMed] 19. Ioudovitch A, Steinberg SV. Structural compensation in an archaeal selenocysteine transfer RNA. J. Mol. Biol. 1999;290:365–371. [PubMed] 20. Bullock TL, Uter N, Nissan TA, Perona JJ. Amino acid discrimination by a class I aminoacyl-tRNA synthetase specified by negative determinants. J. Mol. Biol. 2003;328:395–408. [PubMed] 21. Wolfson AD, Uhlenbeck OC. Modulation of tRNAAla identity by inorganic pyrophosphatase. Proc. Natl Acad. Sci. USA. 2002;99:5965–5970. [PubMed] 22. Schneider KL, Pollard KS, Baertsch R, Pohl A, Lowe TM. The UCSC Archaeal Genome Browser. Nucleic Acids Res. 2006;34:D407–D410. [PubMed] 23. Laslett D, Canback B. ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res. 2004;32:11–16. [PubMed] 24. Korencic D, Polycarpo C, Weygand-Durasevic I, Söll D. Differential modes of transfer RNASer recognition in Methanosarcina barkeri. J. Biol. Chem. 2004;279:48780–48786. [PubMed] 25. Ladner JE, Jack A, Robertus JD, Brown RS, Rhodes D, Clark BF, Klug A. Structure of yeast phenylalanine transfer RNA at 2.5 Å resolution. Proc. Natl Acad. Sci. USA. 1975;72:4414–4418. [PubMed] 26. Moras D, Comarmond MB, Fischer J, Weiss R, Thierry JC, Ebel JP, Giege R. Crystal structure of yeast tRNAAsp. Nature. 1980;288:669–674. [PubMed] 27. Quigley GJ, Seeman NC, Wang AH, Suddath FL, Rich A. Yeast phenylalanine transfer RNA: atomic coordinates and torsion angles. Nucleic Acids Res. 1975;2:2329–2341. [PubMed] 28. Brochier C, Forterre P, Gribaldo S. Archaeal phylogeny based on proteins of the transcription and translation machineries: tackling the Methanopyrus kandleri paradox. Genome Biol. 2004;5:R17. [PubMed] 29. Hatfield DL, Lee BJ, Price NM, Stadtman TC. Selenocysteyl-tRNA occurs in the diatom Thalassiosira and in the ciliate Tetrahymena. Mol. Microbiol. 1991;5:1183–1186. [PubMed] 30. Bilokapic S, Maier T, Ahel D, Gruic-Sovulj I, Söll D, Weygand-Durasevic I, Ban N. Structure of the unusual seryl-tRNA synthetase reveals a distinct zinc-dependent mode of substrate recognition. EMBO J. 2006;25:2498–2509. [PubMed] 31. Fagegaltier D, Hubert N, Yamada K, Mizutani T, Carbon P, Krol A. Characterization of mSelB, a novel mammalian elongation factor for selenoprotein translation. EMBO J. 2000;19:4796–4805. [PubMed] 32. Forchhammer K, Leinfelder W, Böck A. Identification of a novel translation factor necessary for the incorporation of selenocysteine into protein. Nature. 1989;342:453–456. [PubMed] 33. Rother M, Wilting R, Commans S, Böck A. Identification and characterisation of the selenocysteine-specific translation factor SelB from the archaeon Methanococcus jannaschii. J. Mol. Biol. 2000;299:351–358. [PubMed] 34. Oshikane H, Sheppard K, Fukai S, Nakamura Y, Ishitani R, Numata T, Sherrer RL, Feng L, Schmitt E, Panvert M, et al. Structural basis of RNA-dependent recruitment of glutamine to the genetic code. Science. 2006;312:1950–1954. [PubMed] 35. Bailly M, Blaise M, Lorber B, Becker HD, Kern D. The transamidosome: a dynamic ribonucleoprotein particle dedicated to prokaryotic tRNA-dependent asparagine biosynthesis. Mol. Cell. 2007;28:228–239. [PubMed] 36. Giege R, Sissler M, Florentz C. Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res. 1998;26:5017–5035. [PubMed] 37. Bailly M, Giannouli S, Blaise M, Stathopoulos C, Kern D, Becker HD. A single tRNA base pair mediates bacterial tRNA-dependent biosynthesis of asparagine. Nucleic Acids Res. 2006;34:6083–6094. [PubMed] 38. Namgoong S, Sheppard K, Sherrer RL, Söll D. Co-evolution of the archaeal tRNA-dependent amidotransferase GatCAB with tRNAAsn. FEBS Lett. 2007;581:309–314. [PubMed] 39. Sprinzl M, Dank N, Nock S, Schon A. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res. 1991;19:2127–2171. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Eur J Biochem. 2004 Feb; 271(4):694-702.
[Eur J Biochem. 2004]Nature. 1988 Feb 25; 331(6158):723-5.
[Nature. 1988]Nucleic Acids Res. 1993 Dec 11; 21(24):5589-94.
[Nucleic Acids Res. 1993]Proc Natl Acad Sci U S A. 2004 Aug 31; 101(35):12848-53.
[Proc Natl Acad Sci U S A. 2004]Biochemistry. 2005 Oct 11; 44(40):13315-27.
[Biochemistry. 2005]Nature. 1964 Jun 6; 202():984-6.
[Nature. 1964]Proc Natl Acad Sci U S A. 1970 Oct; 67(2):688-95.
[Proc Natl Acad Sci U S A. 1970]Proc Natl Acad Sci U S A. 2004 Aug 31; 101(35):12848-53.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 1982 Oct; 79(20):6215-9.
[Proc Natl Acad Sci U S A. 1982]Nucleic Acids Res. 1977 Jul; 4(7):2123-36.
[Nucleic Acids Res. 1977]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]Eur J Biochem. 2004 Feb; 271(4):694-702.
[Eur J Biochem. 2004]J Mol Biol. 2003 Apr 25; 328(2):395-408.
[J Mol Biol. 2003]Proc Natl Acad Sci U S A. 2002 Apr 30; 99(9):5965-70.
[Proc Natl Acad Sci U S A. 2002]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D407-10.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2004; 32(1):11-6.
[Nucleic Acids Res. 2004]FEBS Lett. 1984 Apr 24; 169(2):319-22.
[FEBS Lett. 1984]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]Proc Natl Acad Sci U S A. 1970 Oct; 67(2):688-95.
[Proc Natl Acad Sci U S A. 1970]Proc Natl Acad Sci U S A. 1982 Oct; 79(20):6215-9.
[Proc Natl Acad Sci U S A. 1982]Nucleic Acids Res. 1977 Jul; 4(7):2123-36.
[Nucleic Acids Res. 1977]Nucleic Acids Res. 1993 Mar 11; 21(5):1073-9.
[Nucleic Acids Res. 1993]Nucleic Acids Res. 1991 Apr 25; 19 Suppl():2127-71.
[Nucleic Acids Res. 1991]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]Proc Natl Acad Sci U S A. 1975 Nov; 72(11):4414-8.
[Proc Natl Acad Sci U S A. 1975]Nature. 1980 Dec 25; 288(5792):669-74.
[Nature. 1980]Nucleic Acids Res. 1975 Dec; 2(12):2329-41.
[Nucleic Acids Res. 1975]Genome Biol. 2004; 5(3):R17.
[Genome Biol. 2004]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]Mol Microbiol. 1991 May; 5(5):1183-6.
[Mol Microbiol. 1991]J Mol Biol. 1993 May 20; 231(2):274-92.
[J Mol Biol. 1993]EMBO J. 2006 Jun 7; 25(11):2498-509.
[EMBO J. 2006]EMBO J. 2000 Sep 1; 19(17):4796-805.
[EMBO J. 2000]Nature. 1989 Nov 23; 342(6248):453-6.
[Nature. 1989]J Mol Biol. 2000 Jun 2; 299(2):351-8.
[J Mol Biol. 2000]Science. 2006 Jun 30; 312(5782):1950-4.
[Science. 2006]Mol Cell. 2007 Oct 26; 28(2):228-39.
[Mol Cell. 2007]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]J Mol Biol. 1993 May 20; 231(2):274-92.
[J Mol Biol. 1993]Nucleic Acids Res. 1993 Mar 11; 21(5):1073-9.
[Nucleic Acids Res. 1993]Proc Natl Acad Sci U S A. 1975 Nov; 72(11):4414-8.
[Proc Natl Acad Sci U S A. 1975]Nature. 1980 Dec 25; 288(5792):669-74.
[Nature. 1980]Nucleic Acids Res. 1975 Dec; 2(12):2329-41.
[Nucleic Acids Res. 1975]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]Nucleic Acids Res. 1998 Nov 15; 26(22):5017-35.
[Nucleic Acids Res. 1998]Nucleic Acids Res. 2006; 34(21):6083-94.
[Nucleic Acids Res. 2006]FEBS Lett. 2007 Jan 23; 581(2):309-14.
[FEBS Lett. 2007]EMBO J. 1994 Jan 1; 13(1):241-8.
[EMBO J. 1994]